The feature, which was announced at Apple’s most recent product launch event in early September, will be available in 150 countries and regions, including the US, Hong Kong and the European Union. The company previously said it was waiting for approval from the FDA and other regulators.
The tool will use data from the Apple Watch’s optical heart sensor to analyze how a user’s…








